IL1B and Sepsis: Although the harmful features of sepsis are thought to be due to the damaging effects caused by over inflammation (20, 26), a number of anti-inflammatory therapies, including anti-endotoxin (27), anti-TNFα (28, 29), anti-IL1 (30), and Toll-like receptor inhibitors (31, 32), have failed in some clinical trial phases.